Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 5Withdrawn 4Unknown 3Recruiting 3Terminated 2Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1Breast 1

Conditions

Ulcer 1Neoplasm Metastasis 1Melanoma 1Desmoid Tumors 1Breast Neoplasms 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Electrochemotherapy × Clear all
NCT06660121 2026-05-14

ECT-DESMO

Istituto Ortopedico Rizzoli

Withdrawn
Sarcoma

Desmoid Tumors

NCT03448666 2024-09-23

ECT-Pembrolizumab in Patients With Unresectable Melanoma With Superficial or Superficial and Visceral Metastases

European Institute of Oncology

Phase 2 Withdrawn
Dermatologic

Melanoma

NCT01479946 2014-12-09

Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin

Uppsala University Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT00918593 2011-09-27

Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy

Copenhagen University Hospital at Herlev

Phase 2 Withdrawn
98 enrolled

Neoplasm Metastasis, Ulcer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡